Classification of Non-Insulin Glucose Lowering Drugs Authors Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, India Saurabh Arora Department of Endocrinology, Dayanand Medical College and Hospital, Ludhiana, India Nitin Kapoor Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India; and Non communicable disease unit, The Nossal Institute for Global Health, Melbourne School of Population and global health, University of Melbourne, Victoria, Australia. DOI: https://doi.org/10.47391/JPMA.22-003 Abstract The ever-changing scenario of diabetes care, especially pharmacotherapy, calls for a framework to help classify non-insulin glucose drugs. Such a taxonomic structure should be of contemporary relevance as well as futuristic in vision; scholarlyin intent but easy to understand; and based on pathophysiologic principles while being useful for the clinician. We propose a rubric which lists four classes of non-insulin glucose lowering drugs; insulin secretagogues, insulin sensitizers, calorierestriction mimetics, and calorie restrictors. This classification serves the need of students and teachers as well as pharmacologists and clinicians alike.Keywords: Alpha glucosidase inhibitors, DPP4i, GLP1RA, liraglutide, pharmacotherapy sulfonylureas, semaglutide, SGLT2i. Downloads Full Text Article Published 2022-02-03 How to Cite Sanjay Kalra, Saurabh Arora, & Nitin Kapoor. (2022). Classification of Non-Insulin Glucose Lowering Drugs. Journal of the Pakistan Medical Association, 72(01). https://doi.org/10.47391/JPMA.22-003 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 72 No. 01 (2022): JANUARY Section PRIMARY CARE DIABETES License Copyright (c) 2022 Journal of the Pakistan Medical Association This work is licensed under a Creative Commons Attribution 4.0 International License.